A major new review of existing research indicates that paracetamol is safe to take during pregnancy and does not increase the risk of autism, ADHD, or developmental issues in children, according to experts. The findings, published in a Lancet journal, contradict claims made last year by former U.S. President Donald Trump, who stated that paracetamol was "no good" and advised pregnant women to avoid it, sparking controversy and criticism from medical organizations worldwide.

The review's authors stated that pregnant women "should feel reassured" by the results, which they believe should put an end to the debate surrounding the painkiller's safety. Trump's earlier assertions, which linked paracetamol use during pregnancy to autism in children, caused confusion among women and concern among health experts, prompting the new research.

The U.S. President's claims were based on the idea that paracetamol, known as acetaminophen in the U.S., could disrupt fetal brain development. This idea gained traction through observational studies, which can show correlation but not causation. These studies are often analyzed using AI techniques to identify patterns and potential risk factors. However, experts caution that AI-driven analysis of observational data can be misleading if not carefully controlled for confounding variables.

The current review employed a meta-analysis approach, combining data from multiple studies to increase statistical power and reduce the risk of bias. This rigorous methodology, considered a gold standard in medical research, strengthens the conclusion that there is no causal link between paracetamol use during pregnancy and neurodevelopmental disorders.

Despite the new findings, U.S. health officials maintain that "many experts" have expressed concern over the use of paracetamol during pregnancy. This highlights the ongoing debate and the need for clear communication to the public about the risks and benefits of medication use during pregnancy.

The implications of this research extend beyond individual health decisions. Misinformation about medical treatments, amplified by social media and AI-driven algorithms, can have significant societal consequences. The incident underscores the importance of critical evaluation of information sources and the need for responsible reporting of scientific findings.

Future research may focus on identifying specific subgroups of women who might be more vulnerable to the effects of paracetamol or exploring alternative pain management strategies during pregnancy. In the meantime, experts recommend that pregnant women consult with their healthcare providers to make informed decisions about medication use based on the best available evidence.